Chronic Cough. Cough-chronic
Conditions
Interventions
Intervention 1: Intervention Group: Licorice lozenges/day for 2 weeks. Patients will be followed at Baseline, 2 weeks and one month after starting intervention. Intervention 2: Placebo Group: Placebo
Treatment - Drugs
Placebo
Intervention Group: Licorice lozenges/day for 2 weeks. Patients will be followed at Baseline, 2 weeks and one month after starting intervention.
Placebo Group: Placebo lozenges/day for 2 weeks. Patients will be followed at Baseline, 2 weeks and one month after starting intervention.
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: patients between 18-70 years old; with resistant idiopathic chronic cough for more than 8 weeks; written informed consent to participate in the project Exclusion criteria: any allergic reaction to the drug; asthma; COPD; GERD; Rhinitis; pregnancy and lactation; hypertension; arrhythmia; Zollinger syndrome; mineralocorticoid and anticoagulants consumers; pregnancy during the study; the drug lost more than three doses; increasing in blood pressure during the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cough severity. Timepoint: Baseline. Method of measurement: Leicester cough questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Cough severity. Timepoint: 2 weeks after treatment and 2 weeks after the end of intervention. Method of measurement: Leicester Cough Questionnaire. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hajar Ghaemi
Shiraz University of Medical Sciences
Outcome results
None listed